Series D - Gemin X Pharmaceuticals - Apr 20, 2010 Funding Round Profile - Cointime

Bitcoin $98,470.32 +0.22%
Ethereum $3,425.20 +0.57%
BNB $672.65 -1.34%
Optimism $2.25 -1.58%
Arbitrum $0.88 +0.64%
Solana $255.44 +0.18%
Polygon $0.57 +0.23%
Cosmos $8.74 -2.73%
Avalanche $46.94 +12.33%

Bitcoin $98,470.32 +0.22%
Ethereum $3,425.20 +0.57%
BNB $672.65 -1.34%
Optimism $2.25 -1.58%
Arbitrum $0.88 +0.64%
Solana $255.44 +0.18%
Polygon $0.57 +0.23%
Cosmos $8.74 -2.73%
Avalanche $46.94 +12.33%

Gemin X Pharmaceuticals

company

Funding Round

Series D

Money Raised

$ 16M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Caxton Advantage Life Sciences Fund	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jul 3, 2008	Series C	$ 38M	Canadian Medical Discoveries Fund,Caxton Advantage Life Sciences Fund,etc.	Detail